Walleye Capital’s 89bio ETNB Stock Holding History

Walleye Capital’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-8,100	Closed	-$119K	–	4716
2025 Q3	$119K	Buy	8,100 +4,400	+119%	+$44.8K	﹤0.01%	3621
2025 Q2	$36.3K	Buy	+3,700	New	+$30.6K	﹤0.01%	4125
2023 Q3	–	Sell	-2,900	Closed	-$55K	–	4997
2023 Q2	$55K	Buy	+2,900	New	+$50.9K	﹤0.01%	3626
2023 Q1	–	Sell	-2,900	Closed	-$36.9K	–	4048
2022 Q4	$36.9K	Buy	+2,900	New	+$26.1K	﹤0.01%	2584

Other funds holding ETNB

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Walleye Capital's ETNB Position: Q4 2025 in Review

Walleye Capital sold out of 89bio (ETNB) in Q4 2025, closing a stake of 24,426 shares — an estimated $359K sold.

Walleye Capital first reported a position in ETNB in Q2 2022 and held it in 11 quarters. The position peaked at $6.11M in Q4 2022. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

Walleye Capital reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
Walleye Capital sold 24,426 89bio shares in Q4 2025, an estimated $359K.
Walleye Capital first reported a position in 89bio in Q2 2022 and held it in 11 quarters.
Walleye Capital's 89bio position peaked at $6.11M in Q4 2022.
2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Walleye Capital's 13F filing for Q4 2025, filed 13 Feb 2026.